For research use only. Not for therapeutic Use.
OP-5244 sodium（Cat No.:I044687）is the sodium salt form of OP-5244, a selective liver X receptor beta (LXRβ) agonist. LXRβ plays a crucial role in regulating cholesterol homeostasis, lipid metabolism, and inflammatory responses. OP-5244 sodium enhances LXRβ activity without significantly affecting LXRα, thereby reducing the risk of lipogenic side effects commonly associated with non-selective LXR agonists. Its sodium formulation improves aqueous solubility and pharmacokinetics for in vivo use. OP-5244 sodium is being explored in preclinical research as a potential therapy for atherosclerosis, autoimmune diseases, and neuroinflammatory disorders, offering a safer LXR-targeted intervention.
| Synonyms | sodium;[(2R)-2-[[(2R,3S,4R,5R)-5-[6-chloro-4-(cyclopentylamino)pyrazolo[3,4-d]pyrimidin-1-yl]-3,4-dihydroxyoxolan-2-yl]methoxy]-1-hydroxy-3-methoxypropan-2-yl]-hydroxyphosphinate |
| Molecular Formula | C19H28ClN5NaO9P |
| Purity | ≥95% |
| Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |
